← Open Payments lookup

KATELYN RIANT: Open Payments

NPI 1396509279 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$744 in 32 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $955 · 2025 $744

Food & beverage: $744
CompanyPaymentsAmount
Eisai Inc.4$94
AstraZeneca Pharmaceuticals LP3$76
Novartis Pharmaceuticals Corporation3$72
GlaxoSmithKline, LLC.3$63
PFIZER INC.3$57
Merck Sharp & Dohme LLC2$57
Bayer Healthcare Pharmaceuticals Inc.2$54
Regeneron Healthcare Solutions, Inc.1$32
Boehringer Ingelheim Pharmaceuticals, Inc.1$29
GENZYME CORPORATION1$26

Products named: Lenvima, KISQALI, KEYTRUDA, Nubeqa, OJJAARA, ENHERTU, LIBTAYO, TAGRISSO.

Industry payments across AL — which companies pay providers there.